Price $22.73 |
Market Cap
2.64B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
9.8
|
P/S
14.01
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-174.5K
|
FCF
-1.4
|
|
Op. Margin
-137.20%
|
Net Margin
-136.00%
|
ROE
-78.60%
|
ROI
-67.00%
|
|
ROA
-68.80%
|
EPS Growth
19.90%
|
Current Ratio
7.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Assertio Therapeutics Inc (ASRT) | $5.92 | - | - | 371.4M | Strong Buy |
| Aquinox Pharmaceuticals Inc (AQXP) | $2.66 | - | - | 68M | Strong Buy |
| Acorda Therapeutics Inc (ACOR) | $18.97 | - | - | 914.1M | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.24 | - | - | 65M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $4.35 | - | - | 37.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
